Sci-Tech Seattle: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Seattle.

Press releases published on May 14, 2026

May 14, 2026

Viamedia Introduces a New Geographic Intelligence Layer for Advertising in a Post‑ID World

Indeterminate GlobeNewswire

May 14, 2026

Evolution Metals & Technologies Enters into Strategic Equipment Purchase Agreements with ULVAC to Scale Annual Rare Earth Magnet Capacity to 10,000 Tons, Including 6,000 Tons of High-Performance Sintered Magnets

Indeterminate GlobeNewswire

May 14, 2026

Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission

Indeterminate GlobeNewswire

May 14, 2026

Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase

Indeterminate GlobeNewswire

May 14, 2026

Orbit International Corp. Reports 2026 First Quarter Results

Indeterminate GlobeNewswire

May 14, 2026

AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer

Indeterminate GlobeNewswire

May 14, 2026

Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers

Indeterminate GlobeNewswire

May 14, 2026

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program

Indeterminate GlobeNewswire

May 14, 2026

Gov. Moore Signs Maryland Digital Asset Task Force and Blockchain Property-Records Bills Into Law

Indeterminate GlobeNewswire

May 14, 2026

GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline

Indeterminate GlobeNewswire

May 14, 2026

Biogen Completes Acquisition of Apellis Pharmaceuticals

Indeterminate GlobeNewswire

May 14, 2026

Helport AI Launches New ‘AI Labor’ Corporate Website

Indeterminate GlobeNewswire

May 14, 2026

20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026

Indeterminate GlobeNewswire

May 14, 2026

Phunware Appoints Dmitry Kroshka as Chief Executive Officer to Lead 2.0 Strategy; Engages Michael Cerdá to Drive Product Rollout

Indeterminate GlobeNewswire

May 14, 2026

Biodexa issues letter to Shareholders

Indeterminate GlobeNewswire

May 14, 2026

Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

Indeterminate GlobeNewswire

May 14, 2026

Exol Announces Strategic Partnership with Manhattan Associates to Unify and Transform Supply Chain Execution

Indeterminate GlobeNewswire

May 14, 2026

FDA Approves New Dosing Option for CRYSVITA® (burosumab-twza) in Adults With XLH

Indeterminate GlobeNewswire

May 14, 2026

Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans

Indeterminate GlobeNewswire

May 14, 2026

Live Ventures Reports Fiscal Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire